Abstract
Purpose: Reduced signal‐to‐noise ratio (SNR) in hyperpolarized 129 Xe MR images can affect accurate quantification for research and diagnostic evaluations. Thus, this study explores the application of supervised deep learning (DL) denoising, traditional (Trad) and Noise2Noise (N2N) and unsupervised Noise2void (N2V) approaches for 129 Xe MR imaging. Methods: The DL denoising frameworks were trained and tested on 952 129 Xe MRI data sets (421 ventilation, 125 diffusion‐weighted, and 406 gas‐exchange acquisitions) from healthy subjects and participants with cardiopulmonary conditions and compared with the block matching 3D denoising technique. Evaluation involved mean signal, noise standard deviation (SD), SNR, and sharpness. Ventilation defect percentage (VDP), apparent diffusion coefficient (ADC), membrane uptake, red blood cell (RBC) transfer, and RBC:Membrane were also evaluated for ventilation, diffusion, and gas‐exchange images, respectively. Results: Denoising methods significantly reduced noise SDs and enhanced SNR ( p < 0.05) across all imaging types. Traditional ventilation model (Trad vent ) improved sharpness in ventilation images but underestimated VDP (bias = −1.37%) relative to raw images, whereas N2N vent overestimated VDP (bias = +1.88%). Block matching 3D and N2V vent showed minimal VDP bias (≤ 0.35%). Denoising significantly reduced ADC mean and SD ( p < 0.05, bias ≤ − 0.63 × 10 −2 ). The values of Trad vent and N2N vent increased mean membrane and RBC ( p < 0.001) with no change in RBC:Membrane. Denoising also reduced SDs of all gas‐exchange metrics ( p < 0.01). Conclusions: Low SNR may impair the potential of 129 Xe MRI for clinical diagnosis and lung function assessment. The evaluation of supervised and unsupervised DL denoising methods enhanced 129 Xe imaging quality, offering promise for improved clinical interpretation and diagnosis.
Funding Information
  • Cystic Fibrosis Foundation (CLEVEL16A0)
  • National Institutes of Health (2R01HL126771, R00HL111217, R01HL131012, R01HL143011, R01HL151588, R01HL166335, R44HL123299)
  • National Organization for Rare Disorders (20003)

This publication has 47 references indexed in Scilit: